FR2299026B1 - - Google Patents

Info

Publication number
FR2299026B1
FR2299026B1 FR7602635A FR7602635A FR2299026B1 FR 2299026 B1 FR2299026 B1 FR 2299026B1 FR 7602635 A FR7602635 A FR 7602635A FR 7602635 A FR7602635 A FR 7602635A FR 2299026 B1 FR2299026 B1 FR 2299026B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7602635A
Other versions
FR2299026A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Smith Kline and French Laboratories Ltd
Original Assignee
Smith Kline and French Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline and French Laboratories Ltd filed Critical Smith Kline and French Laboratories Ltd
Publication of FR2299026A1 publication Critical patent/FR2299026A1/fr
Application granted granted Critical
Publication of FR2299026B1 publication Critical patent/FR2299026B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/32—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/02—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/26—Radicals substituted by sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
FR7602635A 1975-02-03 1976-01-30 Zhiourees et thiocarbamates, procede pour les preparer et compositions pharmaceutiques les contenant Granted FR2299026A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB4538/75A GB1542840A (en) 1975-02-03 1975-02-03 Heterocyclic dithiocarbamates and isothioureas

Publications (2)

Publication Number Publication Date
FR2299026A1 FR2299026A1 (fr) 1976-08-27
FR2299026B1 true FR2299026B1 (fr) 1979-09-21

Family

ID=9779069

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7602635A Granted FR2299026A1 (fr) 1975-02-03 1976-01-30 Zhiourees et thiocarbamates, procede pour les preparer et compositions pharmaceutiques les contenant

Country Status (11)

Country Link
US (1) US4056621A (fr)
JP (3) JPS6044302B2 (fr)
AU (1) AU502509B2 (fr)
BE (1) BE837848A (fr)
CA (1) CA1067501A (fr)
DE (1) DE2604056A1 (fr)
FR (1) FR2299026A1 (fr)
GB (1) GB1542840A (fr)
IE (1) IE42470B1 (fr)
NL (1) NL7600906A (fr)
ZA (1) ZA7682B (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4165378A (en) 1977-04-20 1979-08-21 Ici Americas Inc. Guanidine derivatives of imidazoles and thiazoles
IE47044B1 (en) 1977-04-20 1983-12-14 Ici Ltd Guanidine derivatives
US4239908A (en) * 1979-12-10 1980-12-16 G.D. Searle & Co. N-aralkenyl-N'-cyano-N"-(heterocyclylthioalkyl)-guanidines
JPS57130975A (en) * 1981-02-06 1982-08-13 Fujimoto Seiyaku Kk Preparation of imidazole derivative
JPS57212165A (en) * 1981-06-25 1982-12-27 Fujimoto Seiyaku Kk Imidazole derivative and its preparation
JPS57212166A (en) * 1981-06-25 1982-12-27 Fujimoto Seiyaku Kk Imidazole derivative and its preparation
JPS57212170A (en) * 1981-06-25 1982-12-27 Fujimoto Seiyaku Kk Production of guanidine derivative
US5807884A (en) * 1992-10-30 1998-09-15 Emory University Treatment for atherosclerosis and other cardiovascular and inflammatory diseases
US5380747A (en) * 1992-10-30 1995-01-10 Emory University Treatment for atherosclerosis and other cardiovascular and inflammatory diseases
US5821260A (en) * 1992-10-30 1998-10-13 Emory University Treatment for atherosclerosis and other cardiovascular and inflammatory diseases
US5792787A (en) * 1995-06-07 1998-08-11 Emory University Treatment for atherosclerosis and other cardiovascular and inflammatory diseases
US5922761A (en) * 1996-09-06 1999-07-13 Medinox, Inc. Methods for in vivo reduction of iron levels and compositions useful therefor
EP4196793A1 (fr) 2020-08-11 2023-06-21 Université de Strasbourg Bloqueurs de h2 ciblant des macrophages du foie pour la prévention et le traitement d'une maladie du foie et du cancer

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3458528A (en) * 1965-07-07 1969-07-29 Merck & Co Inc Nitroimidazole carbonates and thionocarbonates
US3773781A (en) * 1966-07-18 1973-11-20 Merck & Co Inc 1-substituted-5-nitroimidazol-2-ylalkyl-(n-substituted)-carbamates
US3790593A (en) * 1966-07-18 1974-02-05 J Carlson 1-substituted-5-nitroimidazol-2-ylalkyl-(n-substituted)-carbamates
BE758146A (fr) * 1969-10-29 1971-04-28 Smith Kline French Lab Derives de l'amidine
US3759944A (en) * 1970-10-14 1973-09-18 Smith Kline French Lab Isothioureas and their derivatives
AU473626B2 (en) * 1972-09-28 1976-06-24 Gd. Searle & Co 2-[2-(2-methyl-5-nitro-1-imidazolyl) ethyl]-2-thiopseudo ureas and related compounds
GB1431589A (en) * 1973-07-13 1976-04-07 Smith Kline French Lab Ureas, thioureas and guanidines n,n-disubstituted by heterocyclo- alkylene and/or heterocycloalkylenethioalkylene groups

Also Published As

Publication number Publication date
IE42470L (en) 1976-08-03
IE42470B1 (en) 1980-08-13
DE2604056A1 (de) 1976-08-05
JPS58150569A (ja) 1983-09-07
JPS58150568A (ja) 1983-09-07
BE837848A (fr) 1976-07-23
NL7600906A (nl) 1976-08-05
AU502509B2 (en) 1979-07-26
US4056621A (en) 1977-11-01
FR2299026A1 (fr) 1976-08-27
JPS6044302B2 (ja) 1985-10-02
GB1542840A (en) 1979-03-28
JPS6343390B2 (fr) 1988-08-30
JPS6343391B2 (fr) 1988-08-30
JPS51101976A (fr) 1976-09-08
CA1067501A (fr) 1979-12-04
ZA7682B (en) 1976-12-29
AU1039476A (en) 1977-07-28

Similar Documents

Publication Publication Date Title
FR2322653B1 (fr)
FR2306281B1 (fr)
JPS5193507A (fr)
JPS5510523Y2 (fr)
JPS5235196U (fr)
JPS5531932Y2 (fr)
JPS5248581U (fr)
JPS5211974U (fr)
JPS5195963A (fr)
AU495836B2 (fr)
JPS5433718Y2 (fr)
JPS5518807B2 (fr)
JPS51145375U (fr)
JPS5273912U (fr)
CH584348A5 (fr)
CH603717A5 (fr)
CH585086A5 (fr)
CH608738A5 (fr)
CH607940A5 (fr)
CH607818A5 (fr)
CH607460A5 (fr)
CH606876A5 (fr)
CH605287A5 (fr)
CH605132A5 (fr)
BG22611A1 (fr)

Legal Events

Date Code Title Description
ST Notification of lapse